Anaridex

📦 Jokainen tilaus on katettuna meidän Reshipment Assurance Policy -politiikkamme piiriin — jos lähetyksesi ei saavu 20 arkipäivässä, lähetämme uuden.

What Is Anaridex?

Anaridex is an oral tablet from Cipla containing anastrozole 1 mg. Anastrozole is a third-generation, non-steroidal, selective aromatase inhibitor used for adjuvant and metastatic treatment of hormone-receptor-positive (HR+) breast cancer in postmenopausal women. Originally developed by AstraZeneca (brand name Arimidex), anastrozole is now a generic standard of care. It is one of the three most-prescribed aromatase inhibitors worldwide alongside exemestane ja letrozole.

How Does Anaridex Work?

In postmenopausal women, ovarian oestrogen production has stopped — circulating oestrogen comes almost entirely from peripheral conversion of adrenal and gonadal androgens (androstenedione, testosterone) by the enzyme aromatase in fat, muscle, liver and breast tissue. Anastrozole reversibly inhibits aromatase, suppressing peripheral oestrogen synthesis by approximately 95% within 24–48 hours.

• Selective non-steroidal aromatase inhibitor — competes with androgen substrate at the aromatase active site without binding the oestrogen receptor itself.
• Postmenopausal-only mechanism — in premenopausal women, the hypothalamic-pituitary-ovarian axis compensates by raising LH/FSH and increasing ovarian aromatase, defeating the suppression. Anastrozole is ineffective in premenopausal women.
• Reversible binding — effect ends within 7–10 days of discontinuation as new aromatase enzyme is synthesised.

Käyttö ja indikaatiot

• Adjuvanttihoidoissa for early HR+ breast cancer in postmenopausal women, typically for 5 years (extended to 10 years in higher-risk disease)
• First-line metastatic HR+ breast cancer in postmenopausal women, often combined with a CDK4/6 inhibitor (palbociclib, ribociclib, abemaciclib)
• Sequential therapy after 2–3 years of tamoksifeeni, switching to an AI for completion of 5–10 years total endocrine therapy
• Off-label: ovulation induction in fertility (specialist use), gynaecomastia in men on testosterone (specialist), male breast cancer (rare)

Anaridex is ei indicated for: premenopausal women (use tamoxifen, or AI + ovarian suppression under specialist guidance), HR-negative breast cancer (no benefit), or non-cancer cosmetic indications.

Anaridex Dosage and How to Take

Vakioannos: 1 mg kerran päivässä. Typical course length:

• Adjuvant breast cancer: 5 years (10 years in high-risk node-positive disease, per ATLAS / aTTom data extrapolated to AIs)
• Metastatic breast cancer: until disease progression or unacceptable toxicity

How to Take Anaridex Properly

1. Take one tablet once daily at approximately the same time each day. Morning or evening — the half-life (~50 hours) means timing has minimal effect on steady-state levels.
2. Ruokailun yhteydessä tai ilman.
3. Nielaiset tabletit kokonaisena veden kanssa.
4. Pakollinen seuranta: baseline DEXA bone-density scan, repeat every 2 years. Annual cholesterol panel. Lipid management as needed.
5. Bone protection: calcium 1,000–1,200 mg/day + vitamin D 800–2,000 IU/day. If osteopenia at baseline or develops, add a bisphosphonate (zoledronic acid IV every 6 months) or denosumab (60 mg SC every 6 months) as standard of care.
6. Joint pain management: regular weight-bearing exercise reduces arthralgia. Paracetamol or NSAIDs for symptomatic relief. Switching to letrozole tai exemestane sometimes helps if anastrozole arthralgia is intolerable.
7. Älä keskeytä ilman onkologin ohjeita. Discontinuation before completion of the planned course significantly increases recurrence risk.
8. Unohdettu annos: if remembered same day, take it. If next day, skip and resume normally — do not double-dose.

Side Effects of Anaridex

Common (oestrogen-deprivation symptoms):

• Hot flushes and night sweats (35–40%)
• Arthralgia (joint pain, stiffness, especially morning) — 30% of patients; main cause of discontinuation
• Myalgia (muscle aches)
• Vaginal dryness, dyspareunia
• Mood changes, low energy
• Hair thinning
• Lievä pahoinvointi

Important long-term:

• Accelerated bone-density loss — fracture risk increased ~30% versus tamoxifen. Mandatory DEXA monitoring and bone-protection.
• Hyperlipidaemia (small increase in total cholesterol and LDL)
• Carpal tunnel syndrome

Less common but seek review:

• Ischaemic cardiac events (small absolute increase, mainly in patients with prior cardiac disease)
• Hepatotoxicity (mild LFT rises common; severe rare)
• Endometrial cancer signal — lower than with tamoxifen, slightly higher than placebo
• Severe hypersensitivity (rare)

Varoitukset ja varotoimet

• Pregnancy: ABSOLUTE CONTRAINDICATION. Anastrozole is teratogenic in animal models. Postmenopausal patients are usually past childbearing potential, but perimenopausal patients require contraception.
• Ennen menopausea olevat naiset: ineffective unless combined with ovarian suppression (GnRH agonist) under specialist oncologist supervision. Default to tamoksifeeni in premenopausal HR+ breast cancer.
• Bone health: baseline DEXA before starting; repeat every 2 years. Calcium + vitamin D supplementation. Consider bisphosphonate or denosumab if osteopenia.
• Sydän- ja verisuonijärjestelmä: small increase in ischaemic cardiac events versus tamoxifen. Address modifiable risk factors. Monitor lipids annually.
• Vakava maksan vajaatoiminta: caution — limited data.
• Concurrent oestrogen therapy (oestrogen-containing HRT or vaginal oestrogen): avoid — defeats the purpose of treatment.

Lääkeaineenvaihdunta

Säilytysohjeet

• Säilytä huoneenlämmössä, 15–25°C. Säilytä alkuperäisessä puskarissa.
• Säilytä lasten ja lemmikkien ulottumattomissa.
• Palauta käyttämättömät tabletit apteekkiin hävitystä varten.

Aiheeseen liittyvät vaihtoehdot MedsBasessa

Muut tämän tuotteen rinnalla varastossa olevat syöpälääkkeet:

• Xtane (exemestane 25 mg)
• Fempro (letrosooli 2,5 mg)
• Letroheal (letrosooli 2,5 mg)
• Tamilong (tamoksifeeni 10 / 20 mg)
• Tamodex (tamoxifen 10 / 20 mg)
• Tamoxilon (tamoxifen 10 / 20 mg)
• Cytotam (tamoxifen 10 / 20 mg)
• Caditam (tamoxifen 20 mg)

Selaa kaikkia syöpälääkkeitä →

Usein Kysytyt Kysymykset

Why is Anaridex only used in postmenopausal women?

In premenopausal women, the hypothalamic-pituitary axis responds to falling oestrogen by raising LH/FSH and increasing ovarian aromatase, defeating the suppression. Anastrozole is therefore ineffective in premenopausal women as monotherapy. The standard endocrine therapy in premenopausal HR+ breast cancer is tamoksifeeni; in higher-risk premenopausal patients, AI + GnRH agonist (ovarian suppression) is sometimes used under specialist supervision.

How long do I take Anaridex for?

Standard adjuvant duration is 5 vuotta. For higher-risk node-positive disease, extended therapy to 7–10 years is increasingly recommended (extrapolated from ATLAS and aTTom tamoxifen data and AI extension trials such as MA.17R). For metastatic disease, anastrozole continues until progression or intolerable toxicity.

How do I manage joint pain on Anaridex?

Aromatase inhibitor arthralgia affects ~30% of patients and is the main reason for premature discontinuation. First-line measures: regular weight-bearing exercise (yoga, walking, swimming), vitamin D 1,000–2,000 IU/day, paracetamol or short courses of NSAIDs, weight management. If intolerable, switching to letrozole tai exemestane sometimes helps — about 30% of patients tolerate one AI but not another.

Will Anaridex weaken my bones?

Yes — aromatase inhibitors accelerate bone-density loss with about 30% increased fracture risk versus tamoxifen. Mandatory baseline DEXA scan, repeat every 2 years. Calcium + vitamin D supplementation is standard. If osteopenia develops, add a bisphosphonate (zoledronic acid IV every 6 months) or denosumab (60 mg SC every 6 months) — this is now standard of care and should be discussed with the oncologist.

Can I use vaginal oestrogen for dryness while on Anaridex?

Generally not recommended — even low-dose vaginal oestrogen produces measurable systemic absorption that can defeat AI therapy. First-line: non-hormonal vaginal moisturisers (Replens, hyaluronic acid gels) and water-based lubricants. If symptoms are intolerable, a specialist may consider very low-dose vaginal oestriol on an individual risk-benefit basis (vaginal oestriol has lower systemic absorption than oestradiol).

Anaridex vs tamoxifen vs letrozole vs exemestane — which is right for me?

This is an oncologist decision based on your menopausal status, tumour biology, and side-effect profile. Broad pattern: premenopausal HR+ → tamoksifeeni first-line. Postmenopausal HR+ → AI (anastrozole / letrozole / exemestane) first-line, with switch to tamoxifen as 2nd-line if AI intolerance. The three AIs have similar efficacy. Anastrozole and letrozole are non-steroidal; exemestane is steroidal and structurally distinct. Switching between AIs is reasonable for intolerable side effects.

Is Anaridex safe in pregnancy?

Absolutely not. Anastrozole is contraindicated in pregnancy and breastfeeding. Postmenopausal patients are usually past childbearing potential, but perimenopausal patients (chemotherapy-induced amenorrhoea may not be permanent) need reliable non-hormonal contraception throughout treatment.

Can I take Anaridex with my heart medications?

Anastrozole has minimal direct interactions with cardiovascular medications. The relevant clinical concern is the small increased risk of ischaemic cardiac events on AI therapy versus tamoxifen, particularly in patients with established cardiac disease. Optimise modifiable cardiac risk factors (statins for hyperlipidaemia, BP control, smoking cessation, exercise) and discuss any chest pain promptly.

What happens if I stop Anaridex early?

Stopping adjuvant aromatase inhibitor therapy before completion of the planned 5–10 years course significantly increases breast cancer recurrence risk. Real-world data show that fewer than 50% of patients complete the full 5 years — usually because of arthralgia and quality-of-life impact. Always discuss intolerable side effects with your oncologist before stopping — switching AI, dose modifications, supportive care, and acupuncture for arthralgia are all options before discontinuation.

Miksi tilata MedsBasesta

Jokainen erä on hankittu WHO-GMP sertifioitu valmistaja. Tilaukset toimitetaan yksinkertaisessa, brändittömässä pakkauksessa täyttöpartneriemme kautta ja niihin kuuluu Reshipment Assurance Policy -politiikkamme piiriin: jos lähetys ei saavu 20 arkipäivän kuluessa, lähetämme uuden ilmaiseksi, kysymättä lisäkysymyksiä.

Aiheeseen liittyvät syöpälääkkeet

Muut tämän tuotteen rinnalla varastossa olevat syöpälääkkeet:

• Xtane (exemestane 25 mg)
• Letroheal (letrosooli 2,5 mg)
• Fempro (letrosooli 2,5 mg)
• Tamilong (tamoxifen 10/20 mg)
• Tamodex (tamoxifen 10/20 mg)

Lisää vaihtoehtoja syöpälääkkeissä

Luokiteltu MedsBase-tilausmäärän mukaan — mitä muut asiakkaat tässä kategoriassa valitsevat.

Imat

US$79.00 – US$310.00Prisintervall: US$79.00 till US$310.00